News
-
-
PRESS RELEASE
aap confirms growth course at the start of 2026 – revenue slightly above previous year, strong momentum in the USA
aap Implantate AG reports positive sales growth in Q1 2026, USA drives revenue increase, certifications completed for CE markets, resilient business model in geopolitical challenges -
-
-
-
PRESS RELEASE
aap successfully completes MDR certification: All existing products approved according to MDR – market access in the EU and CE-relevant markets secured in the long term
aap Implantate AG successfully completes MDR certification for all existing products, ensuring market access in EU and CE-relevant markets in the long term. Focus shifts to new product development -
-
PRESS RELEASE
Further growth in the fourth quarter leads to annual sales of EUR 12.5 million (+2%); Important milestone achieved in antibacterial implants
aap Implantate AG reports 2% sales growth, reaching EUR 12.5 million in annual sales; Achieves milestone in antibacterial implants development, with successful human trials -
-
